| abstract |
The present invention relates to a substituted tetrahydrothienopyridine of the general formula (1), a process for producing the same, a medicament containing this compound, and pain, epilepsy, urinary incontinence, anxiety, dependence, mania, bipolar disorder, migraine, cognition diseases, relates to the use of this compound for the manufacture of a medicament for the treatment of dystonia associated dyskinesia and / or urinary incontinence, a 1 is S, a 2 is CR 14, and a 3 is a CR 15 Or A 1 is CR 13 , A 2 is S, and A 3 is CR 15 ; or A 1 is CR 13 , A 2 is CR 14 , and A 3 is S It is. |